CTOs on the Move

Glympse Bio

www.glympsebio.com

 
Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.glympsebio.com
  • LabCentral, 700 Main Street
    Cambridge, MA USA 02139
  • Phone: 617.863.3650

Executives

Name Title Contact Details

Funding

Glympse Bio raised $22M on 10/09/2018
Glympse Bio raised $46.7M on 07/15/2020

Similar Companies

CORRECT PHARMACY

CORRECT PHARMACY is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Interpace Biosciences

Interpace Biosciences is a company that provides molecular and related first line diagnostic tests for evaluating risk of cancer, as well as specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted...

Stemline Therapeutics

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.

Empirico

Empirico is a venture-backed, next-generation therapeutics company founded on utilizing huge biological data sets, human genetics and programmable biology to power novel target discovery and development.

BD Biosciences - Canada

BD Biosciences - Canada is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.